TP53 and cancer: Using bioinformatics (in silico) analyses, Singh and Bharara [190] proved that the S2 subunit of SARS-CoV-2 strongly interacts with well-known tumor suppressor proteins p53 and BRCA1/2, which are frequently mutated in human cancers.